Total Payments
$1,143
2024 Payments
$48.37
Companies
21
Transactions
57
Medicare Patients
1,277
Medicare Billing
$295,899
Payment Breakdown by Category
Food & Beverage$1,143 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,143 | 57 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $238.81 | 7 | $0 (2019) |
| GENZYME CORPORATION | $133.03 | 6 | $0 (2019) |
| PFIZER INC. | $104.66 | 8 | $0 (2019) |
| Genentech USA, Inc. | $98.16 | 6 | $0 (2019) |
| Janssen Scientific Affairs, LLC | $91.45 | 1 | $0 (2017) |
| Amgen Inc. | $81.92 | 4 | $0 (2020) |
| Galderma Laboratories, L.P. | $70.05 | 5 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $48.37 | 1 | $0 (2024) |
| Aqua Pharmaceuticals | $36.61 | 2 | $0 (2017) |
| AbbVie, Inc. | $31.51 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $48.37 | 1 | E.R. Squibb & Sons, L.L.C. ($48.37) |
| 2021 | $13.74 | 1 | Galderma Laboratories, L.P. ($13.74) |
| 2020 | $58.79 | 3 | Amgen Inc. ($41.01) |
| 2019 | $261.06 | 16 | GENZYME CORPORATION ($43.58) |
| 2018 | $250.86 | 14 | Celgene Corporation ($71.47) |
| 2017 | $509.77 | 22 | Celgene Corporation ($126.96) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/17/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $48.37 | General |
| Category: Immunology | ||||||
| 01/22/2021 | Galderma Laboratories, L.P. | ORACEA (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: ROSACEA | ||||||
| 11/12/2020 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Inflammation | ||||||
| 08/19/2020 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Immunology | ||||||
| 05/07/2020 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: Inflammation | ||||||
| 12/05/2019 | Amgen Inc. | Otezla (Biological) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Inflammation | ||||||
| 11/07/2019 | Galderma Laboratories, L.P. | SOOLANTRA (Drug), EPIDUO FORTE | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: ROSACEA | ||||||
| 09/17/2019 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: DERMATOLOGY | ||||||
| 09/12/2019 | GENZYME CORPORATION | LIBTAYO (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: ONCOLOGY | ||||||
| 08/22/2019 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: DERMATOLOGY | ||||||
| 08/21/2019 | DERMIRA, INC. | — | Food and Beverage | In-kind items and services | $15.17 | General |
| 08/15/2019 | Genentech USA, Inc. | Erivedge (Biological) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: BioOncology | ||||||
| 05/30/2019 | Helsinn Therapeutics (U.S.), Inc. | VALCHLOR (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: ONCOLOGY | ||||||
| 04/11/2019 | Galderma Laboratories, L.P. | SOOLANTRA (Drug), ORACEA, EPIDUO FORTE | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: ROSACEA | ||||||
| 04/08/2019 | Ortho Dermatologics, a division of Bausch Health US, LLC | ALTRENO (Drug), RETIN-A MICRO, ONEXTON | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: DERMATOLOGY | ||||||
| 04/03/2019 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: ONCOLOGY | ||||||
| 03/21/2019 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $19.18 | General |
| 02/20/2019 | Celgene Corporation | — | Food and Beverage | In-kind items and services | $21.20 | General |
| 02/14/2019 | GENZYME CORPORATION | DUPIXENT (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: IMMUNOLOGY | ||||||
| 02/06/2019 | PruGen, Inc. Pharmaceuticals | — | Food and Beverage | In-kind items and services | $15.27 | General |
| 02/06/2019 | PruGen, Inc. Pharmaceuticals | — | Food and Beverage | In-kind items and services | $0.19 | General |
| 11/08/2018 | PFIZER INC. | EUCRISA (Drug) | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: DERMATOLOGY | ||||||
| 10/11/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Immunology | ||||||
| 09/16/2018 | Biofrontera Inc. | Ameluz (Drug), BF-RhodoLED | Food and Beverage | Cash or cash equivalent | $22.95 | General |
| Category: Dermatology | ||||||
| 09/04/2018 | Genentech USA, Inc. | Rituxan (Biological) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: BioOncology/Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 5 | 131 | 198 | $186,297 | $24,089 |
| 2020 | 19 | 1,146 | 1,607 | $1.9M | $271,810 |
Total Patients
1,277
Total Services
1,805
Medicare Billing
$295,899
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals (first stage, up to 5 tissue blocks) | Office | 2021 | 35 | 44 | $128,890 | $19,117 | 14.8% |
| 13132 | Repair of wound (2.6 to 7.5 centimeters) of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, and/or feet | Office | 2021 | 15 | 15 | $36,579 | $2,811 | 7.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 40 | 40 | $7,541 | $1,147 | 15.2% |
| 17000 | Destruction of skin growth | Office | 2021 | 24 | 26 | $7,894 | $720.84 | 9.1% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 17 | 73 | $5,393 | $291.96 | 5.4% |
| 17311 | Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals (first stage, up to 5 tissue blocks) | Office | 2020 | 247 | 314 | $919,803 | $143,068 | 15.6% |
| 17312 | Removal and microscopic examination of growth of the head, neck, hands, feet, or genitals | Office | 2020 | 88 | 132 | $235,138 | $40,902 | 17.4% |
| 17313 | Removal and microscopic examination of growth of the trunk, arms, or legs (first stage, up to 5 tissue blocks) | Office | 2020 | 35 | 38 | $102,288 | $16,773 | 16.4% |
| 13132 | Repair of wound (2.6 to 7.5 centimeters) of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, and/or feet | Office | 2020 | 73 | 76 | $185,331 | $14,187 | 7.7% |
| 12032 | Repair of wound (2.6 to 7.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs | Office | 2020 | 52 | 54 | $46,139 | $8,538 | 18.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 126 | 159 | $29,975 | $6,571 | 21.9% |
| 12052 | Repair of wound (2.6 to 5.0 centimeters) of face, ears, eyelids, nose, lips, and/or mouth | Office | 2020 | 43 | 43 | $44,959 | $5,243 | 11.7% |
| 13121 | Repair of wound (2.6 to 7.5 centimeters) of scalp, arms, and/or legs | Office | 2020 | 28 | 30 | $49,489 | $5,203 | 10.5% |
| 17000 | Destruction of skin growth | Office | 2020 | 135 | 157 | $47,670 | $4,619 | 9.7% |
| 13152 | Repair of wound (2.6 to 7.5 centimeters) of eyelids, nose, ears, and/or lips | Office | 2020 | 21 | 21 | $63,814 | $4,139 | 6.5% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 47 | 53 | $18,104 | $3,689 | 20.4% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 55 | 64 | $18,357 | $3,658 | 19.9% |
| 12042 | Repair of wound (2.6 to 7.5 centimeters) of neck, hands, feet, and/or genitals | Office | 2020 | 30 | 30 | $27,603 | $3,551 | 12.9% |
| 11602 | Removal of malignant growth (1.1 to 2.0 centimeters) of the trunk, arms, or legs | Office | 2020 | 28 | 35 | $32,765 | $3,380 | 10.3% |
| 12051 | Repair of wound (2.5 centimeters or less) of face, ears, eyelids, nose, lips, and/or mouth | Office | 2020 | 24 | 24 | $22,082 | $2,543 | 11.5% |
| 13151 | Repair of wound (1.1 to 2.5 centimeters) of eyelids, nose, ears, and/or lips | Office | 2020 | 15 | 15 | $23,321 | $2,501 | 10.7% |
| 17003 | Destruction of 2-14 skin growths | Office | 2020 | 72 | 328 | $24,233 | $1,354 | 5.6% |
| 88331 | Pathology examination of tissue during surgery | Office | 2020 | 13 | 15 | $8,808 | $1,171 | 13.3% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2020 | 14 | 19 | $2,939 | $719.27 | 24.5% |
About Dr. David Bertler, M.D
Dr. David Bertler, M.D is a Dermatology healthcare provider based in De Pere, Wisconsin. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083657555.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Bertler, M.D has received a total of $1,143 in payments from pharmaceutical and medical device companies, with $48.37 received in 2024. These payments were reported across 57 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($1,143).
As a Medicare-enrolled provider, Bertler has provided services to 1,277 Medicare beneficiaries, totaling 1,805 services with total Medicare billing of $295,899. Data is available for 2 years (2020–2021), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Other Specialties Procedural Dermatology, MOHS-Micrographic Surgery
- Location De Pere, WI
- Active Since 06/13/2006
- Last Updated 03/07/2023
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1083657555
Products in Payments
- Otezla (Drug) $187.02
- EUCRISA (Drug) $104.66
- STELARA (Biological) $91.45
- DERMATITIS - DISEASE (Drug) $89.45
- Erivedge (Biological) $84.24
- Sotyktu (Drug) $48.37
- SOOLANTRA (Drug) $45.50
- Humira (Biological) $31.51
- COSENTYX (Biological) $24.73
- ORACEA (Drug) $24.55
- DUPIXENT (Drug) $23.97
- Otezla (Biological) $23.87
- Ameluz (Drug) $22.95
- Cordran (Drug) $22.29
- ENSTILAR (Drug) $22.22
- LIBTAYO (Drug) $19.61
- TREMFYA (Drug) $17.78
- LIBTAYO (Biological) $17.76
- Enbrel (Biological) $17.04
- SILIQ (Drug) $15.53
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.